Cargando…

Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism

BACKGROUND: For neurons to function correctly in neuronal circuitry they must utilize appropriate neurotransmitters. However, even though neurotransmitter specificity is one of the most important and defining properties of a neuron we still do not fully understand how neurotransmitter fates are spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Juárez-Morales, José L., Schulte, Claus J., Pezoa, Sofia A., Vallejo, Grace K., Hilinski, William C., England, Samantha J., de Jager, Sarah, Lewis, Katharine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759709/
https://www.ncbi.nlm.nih.gov/pubmed/26896392
http://dx.doi.org/10.1186/s13064-016-0059-9
_version_ 1782416771045654528
author Juárez-Morales, José L.
Schulte, Claus J.
Pezoa, Sofia A.
Vallejo, Grace K.
Hilinski, William C.
England, Samantha J.
de Jager, Sarah
Lewis, Katharine E.
author_facet Juárez-Morales, José L.
Schulte, Claus J.
Pezoa, Sofia A.
Vallejo, Grace K.
Hilinski, William C.
England, Samantha J.
de Jager, Sarah
Lewis, Katharine E.
author_sort Juárez-Morales, José L.
collection PubMed
description BACKGROUND: For neurons to function correctly in neuronal circuitry they must utilize appropriate neurotransmitters. However, even though neurotransmitter specificity is one of the most important and defining properties of a neuron we still do not fully understand how neurotransmitter fates are specified during development. Most neuronal properties are determined by the transcription factors that neurons express as they start to differentiate. While we know a few transcription factors that specify the neurotransmitter fates of particular neurons, there are still many spinal neurons for which the transcription factors specifying this critical phenotype are unknown. Strikingly, all of the transcription factors that have been identified so far as specifying inhibitory fates in the spinal cord act through Pax2. Even Tlx1 and Tlx3, which specify the excitatory fates of dI3 and dI5 spinal neurons work at least in part by down-regulating Pax2. METHODS: In this paper we use single and double mutant zebrafish embryos to identify the spinal cord functions of Evx1 and Evx2. RESULTS: We demonstrate that Evx1 and Evx2 are expressed by spinal cord V0v cells and we show that these cells develop into excitatory (glutamatergic) Commissural Ascending (CoSA) interneurons. In the absence of both Evx1 and Evx2, V0v cells still form and develop a CoSA morphology. However, they lose their excitatory fate and instead express markers of a glycinergic fate. Interestingly, they do not express Pax2, suggesting that they are acquiring their inhibitory fate through a novel Pax2-independent mechanism. CONCLUSIONS: Evx1 and Evx2 are required, partially redundantly, for spinal cord V0v cells to become excitatory (glutamatergic) interneurons. These results significantly increase our understanding of the mechanisms of neuronal specification and the genetic networks involved in these processes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13064-016-0059-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4759709
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47597092016-02-20 Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism Juárez-Morales, José L. Schulte, Claus J. Pezoa, Sofia A. Vallejo, Grace K. Hilinski, William C. England, Samantha J. de Jager, Sarah Lewis, Katharine E. Neural Dev Research Article BACKGROUND: For neurons to function correctly in neuronal circuitry they must utilize appropriate neurotransmitters. However, even though neurotransmitter specificity is one of the most important and defining properties of a neuron we still do not fully understand how neurotransmitter fates are specified during development. Most neuronal properties are determined by the transcription factors that neurons express as they start to differentiate. While we know a few transcription factors that specify the neurotransmitter fates of particular neurons, there are still many spinal neurons for which the transcription factors specifying this critical phenotype are unknown. Strikingly, all of the transcription factors that have been identified so far as specifying inhibitory fates in the spinal cord act through Pax2. Even Tlx1 and Tlx3, which specify the excitatory fates of dI3 and dI5 spinal neurons work at least in part by down-regulating Pax2. METHODS: In this paper we use single and double mutant zebrafish embryos to identify the spinal cord functions of Evx1 and Evx2. RESULTS: We demonstrate that Evx1 and Evx2 are expressed by spinal cord V0v cells and we show that these cells develop into excitatory (glutamatergic) Commissural Ascending (CoSA) interneurons. In the absence of both Evx1 and Evx2, V0v cells still form and develop a CoSA morphology. However, they lose their excitatory fate and instead express markers of a glycinergic fate. Interestingly, they do not express Pax2, suggesting that they are acquiring their inhibitory fate through a novel Pax2-independent mechanism. CONCLUSIONS: Evx1 and Evx2 are required, partially redundantly, for spinal cord V0v cells to become excitatory (glutamatergic) interneurons. These results significantly increase our understanding of the mechanisms of neuronal specification and the genetic networks involved in these processes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13064-016-0059-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-19 /pmc/articles/PMC4759709/ /pubmed/26896392 http://dx.doi.org/10.1186/s13064-016-0059-9 Text en © Juárez-Morales et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Juárez-Morales, José L.
Schulte, Claus J.
Pezoa, Sofia A.
Vallejo, Grace K.
Hilinski, William C.
England, Samantha J.
de Jager, Sarah
Lewis, Katharine E.
Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title_full Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title_fullStr Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title_full_unstemmed Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title_short Evx1 and Evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a Pax2-independent mechanism
title_sort evx1 and evx2 specify excitatory neurotransmitter fates and suppress inhibitory fates through a pax2-independent mechanism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759709/
https://www.ncbi.nlm.nih.gov/pubmed/26896392
http://dx.doi.org/10.1186/s13064-016-0059-9
work_keys_str_mv AT juarezmoralesjosel evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT schulteclausj evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT pezoasofiaa evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT vallejogracek evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT hilinskiwilliamc evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT englandsamanthaj evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT dejagersarah evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism
AT lewiskatharinee evx1andevx2specifyexcitatoryneurotransmitterfatesandsuppressinhibitoryfatesthroughapax2independentmechanism